Ampicillin sulbactam overdosage: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 4: | Line 4: | ||
==Overdosage== | ==Overdosage== | ||
Neurological adverse reactions, including [[convulsion]]s, may occur with the attainment of high CSF levels of beta- | |||
Neurological adverse reactions, including [[convulsion]]s, may occur with the attainment of high [[CSF]] levels of [[beta-lactam]]s. Ampicillin may be removed from circulation by hemodialysis. The molecular weight, degree of protein binding and pharmacokinetics profile of sulbactam suggest that this compound may also be removed by hemodialysis.<ref>{{Cite web| last = | first = |title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050608s040lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050608s040lbl.pdf | publisher = |date = | accessdate = }}</ref> | |||
==References== | ==References== |
Latest revision as of 01:00, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overdosage
Neurological adverse reactions, including convulsions, may occur with the attainment of high CSF levels of beta-lactams. Ampicillin may be removed from circulation by hemodialysis. The molecular weight, degree of protein binding and pharmacokinetics profile of sulbactam suggest that this compound may also be removed by hemodialysis.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050608s040lbl.pdf" (PDF). External link in
|title=
(help)
Adapted from the FDA Package Insert.